Since 2021, aggregated from related topics
Viral protease inhibition is a research area focused on the development of drugs that target and block the activity of protease enzymes produced by viruses. These enzymes are essential for the replication of viruses and are involved in the cleavage of viral proteins necessary for their assembly and maturation. By inhibiting viral proteases, researchers aim to disrupt the viral life cycle and prevent the spread of infection. This research area is important for the development of antiviral therapies to treat a wide range of viral diseases, including HIV, hepatitis C, and COVID-19.